Published in Biotech Business Week, January 24th, 2005
Bone morphogenic proteins (BMP) - a new and innovative class of natural growth factors - represent among the most exciting of these niches.
Still pending marketing approval for use in spinal surgery across Europe, BMP promises to offer an improvement on existing spinal fusion techniques.
The increased incidence of degenerative diseases of the lower back is expected to be a key growth driver in the BMP market. As more people opt for surgical procedures to alleviate back pain...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.